S3 products Archives | Cannabiz

Cann Group progresses S3 commercial talks with Haleon

by Steve Jones November 7, 2022April 29, 2024

Cann Group has “positively progressed” commercial negotiations with GlaxoSmithKline’s consumer healthcare division, Haleon, over the potential […]

Bod’s S3 registration candidate to go on sale through Special Access Scheme

by Steve Jones June 27, 2022April 29, 2024

Avecho ‘adamant’ that S3 insomnia trial must be accepted overseas

by Steve Jones May 4, 2022April 29, 2024

Cann Group eyes S3 product and the end of ‘unsophisticated’ formulations

by Steve Jones February 18, 2021April 26, 2024